Depression and risk of stroke and mortality after percutaneous coronary intervention: A nationwide population study

Dae Young Cheon1, Yong-Moon Park2,3, Myung Soo Park1

  • 1Division of Cardiology, Department of Internal Medicine, Dongtan Sacred Heart Hospital, Hwaseong, South Korea.

PubMed

Insights

Pre-existing depression increases stroke and death risk after percutaneous coronary intervention (PCI). Managing depression may improve cardiovascular outcomes in PCI patients, especially those under 65.

Area of Science:

  • Cardiovascular Medicine
  • Psychiatry
  • Public Health

Background:

  • Limited evidence links depression to adverse outcomes post-percutaneous coronary intervention (PCI).
  • Investigating depression's role in stroke and cardiovascular risk after PCI is crucial.

Purpose of the Study:

  • To examine the association between pre-existing depression and the risk of new-onset stroke and other cardiovascular outcomes in patients who underwent PCI.

Main Methods:

  • A nationwide retrospective cohort study of 164,198 patients who underwent PCI between 2010-2017.
  • Depression was identified using ICD-10 codes prior to PCI.
  • Multivariable Cox regression analysis assessed outcomes including stroke, myocardial infarction, revascularization, and all-cause mortality.

Main Results:

  • Depression was associated with a 27% increased risk of acute stroke (aHR 1.27) and a 25% increased risk of all-cause mortality (aHR 1.25).
  • An 8% increased risk of revascularization (aHR 1.08) was also observed in patients with depression.
  • These associations were more pronounced in patients under 65 years.

Conclusions:

  • Pre-existing depression is linked to higher risks of stroke and mortality following PCI.
  • Depression management may be beneficial for reducing stroke risk and improving cardiovascular outcomes post-PCI.
  • The impact of depression on outcomes is particularly significant in younger patients (<65 years).
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
26
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Coronary Artery Disease V: Surgical Management01:27

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
3